Managing patients with sickle cell disease in primary care

Area of Science:

• Hematology
• Genetics
• Public Health

Background:

• Sickle cell disease (SCD) is a genetic blood disorder affecting hemoglobin in red blood cells.
• SCD leads to significant illness and death, predominantly in individuals of African ancestry.
• Current management practices are guided by updated 2014 clinical recommendations.

Purpose of the Study:

• To review the 2014 National Heart, Lung, and Blood Institute guidelines for SCD management.
• To highlight key aspects of health maintenance for patients with SCD.
• To discuss the role of hydroxyurea in SCD treatment.

Main Methods:

• Review of evidence-based recommendations from the 2014 National Heart, Lung, and Blood Institute guidelines.
• Synthesis of information pertaining to health maintenance strategies.
• Analysis of data and literature concerning hydroxyurea therapy.

Main Results:

• The 2014 guidelines provide a framework for comprehensive SCD care.
• Proactive health maintenance is crucial for reducing morbidity and mortality.
• Hydroxyurea is a key therapeutic agent in managing SCD.

Conclusions:

• Adherence to updated clinical guidelines is essential for optimal SCD patient outcomes.
• Effective health maintenance and targeted therapies like hydroxyurea improve quality of life for individuals with SCD.
• Primary care clinicians play a vital role in implementing evidence-based SCD management strategies.